Searchable abstracts of presentations at key conferences in endocrinology

ea0085p71 | Miscellaneous 2 | BSPED2022

Evaluation of a new multidisciplinary clinic for the endocrine assessment of patients with duchenne muscular dystrophy

Malhotra Neha , Sarkozy Anna , Allgrove Jeremy , Brain Caroline , Manzur Adnan , Chesover Alexander D

Introduction The endocrine assessment of children with Duchenne muscular dystrophy (DMD) can be necessary for management of osteoporosis, delayed puberty, obesity, adrenal insufficiency, and short stature. With ongoing implementation of the international standards of care for DMD, referrals to our Metabolic Bone Clinic (MBC) increased beyond its capacity, impacting patient care. The neuromuscular and endocrine departments implemented a new referral pathway and Multidis...

ea0033oc1.6 | Oral Communications 1 | BSPED2013

Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy

Srinivasan Ramesh , Rawlings David , Cheetham Tim , Sarkozy Anna , Bushby Kate , Owen Catherine

Background: Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy, resulting in death at a young age. Corticosteroids improve muscle function and slow disease progression. However long-term steroid therapy is a significant risk factor for osteoporosis.Aim: To assess the effect of oral bisphosphonate (risedronate) treatment on bone mineral density in a cohort of steroid-treated children with DMD.Method: Annual bone...